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Abstract
Background: Ciji Hua’ai Baosheng Granule Formula (CHBGF) is a traditional Chinese empirical formula that can help the tumor patients who
have received chemotherapy antagonize the toxin and side-effects so as to improve and prolong the life. This study is to evaluate the effects of
CHBGF on improving life quality in terms of survival time, pathology of tumor tissue and ameliorating peripheral blood cells in mouse
chemotherapy model with subcutaneous transplanted tumor or ascitic tumor of H22 hepatoma carcinoma cells at an overall level.
Materials and Methods: 71 mice among the 92 Kunming mice were injected subcutaneously into the right anterior armpit with H22 hepatoma
carcinoma cells, after 7 days, which had formed tumors and were used peritoneal injection of Cytoxan (CTX) (200mg/kg) to establish the
mouse chemotherapy model with transplanted tumor, and then which were commensurately divided into 8 groups by random digits table. 21
mice were injected into peritoneal cavity to use CTX and the same method to establish the model. The groups for evaluating the effects on the
survival time were the model, CHBGF and positive control group respectively with 7 mice in each group. The groups for evaluating the effects
on anti-cancer were the model group, three treatment groups and positive control group with 10 mice in each group. The
survival-time-observing groups were given intragastric administration of normal saline, CHBGF (64g/kg) once a day, and peritoneal injection
of 5-Fluorouracil (25mg/kg) once every other day respectively. The survival time of each group was observed. The five anti-cancer-observing
groups were given intragastric administration of normal saline, CHBGF (64g/kg, 32g/kg and 16g/kg) once a day, and peritoneal injection of
5-Fluorouracil (25mg/kg) once every other day respectively. After treatment for 21 days, the transplanted tumors were peeled off. Blood was
collected through pricking eyeball and analyzed by hematology analyzer. And postchemotherapy transplanted tumor inhibition ratios were
calculated. Pathological changes of tumor tissues and blood smears were observed with light microscope.
Results: The life prolonging rate of CHBGF (64g/kg) group with transplanted tumor is 20.14%, and their survival time was longer than that of
the 5-Fluorouracil group (P<0.05). Life prolonging rate of CHBGF (64g/kg) group with ascitic tumor is 64.15%, the survival time was longer
than that of the model group (P<0.01) and the 5-Fluorouracil group (P<0.05). The growth of the transplanted tumor in model group was faster
than that in CHBGF (64g/kg) group and 5-Fluorouracil group (P<0.05). The tumor average weight of the positive drug and the CHBGF
(64g/kg, 32g/kg) groups was lighter than that of the model group (P<0.05 or P<0.01). The inhibition ratios of CHBGF (64g/kg, 32g/kg and
16g/kg) groups are 31.15%, 21.31%, and 13.11% respectively. Under light microscope, in the positive drug and three CHBGF groups the
pathological deteriorated severity of tumor tissue observed was milder than that in the model group, the distribution of WBC in CHBGF groups
was more obvious than that of the model and 5-Fluorouracil groups. The WBC and PLT decrease in CHBGF (64g/kg, 32g/kg and 16g/kg)
groups is less than the model and the 5-Fluorouracil group (P<0.05 or P<0.01), the number of RBC and HGB just in the CHBGF (64g/kg)
group was more than that of the model group or the 5-Fluorouracil group (P<0.05).
Conclusion: Ciji Hua’ai Baosheng Granule Formula can prolong the survival time of the mice chemotherapy model of both subcutaneous
transplanted tumor and ascitic tumor of H22 hepatoma carcinoma cells, has some determinate inhibitory effects on the growth of subcutaneous
transplanted tumor chemo-treated, and has the therapeutic effect on antagonizing decrease of WBC and PLT caused by chemotherapy.
Key words: Ciji Hua’ai Baosheng Granule Formula (CHBGF); tumor chemotherapy model; transplanted tumor; ascitic tumor; survival time;
pathology; peripheral blood cell; H22 hepatoma carcinoma cell.
Introduction
Hepatic cancer is one of the most common human malignancies worldwide and its incidence rate is increasing year by year, with over
0.748 million new cases and 0.696 million deaths in 2010 (Jemal et al., 2011). To date, chemotherapy is still the major remedy for patients with
the advanced hepatic cancer. The application of many anti-cancer chemotherapeutics used currently like 5-Fluorouracil, Cyclophosphamide and
others is very extensive, but these chemotherapeutics will generate unacceptable level of toxicity to normal cells and tissue. Drug toxicity
especially the myelosuppression reaction limits the effectiveness of current hepatic cancer chemotherapy, increasing the necessity for the
development of new therapeutic methods. Natural products, including traditional Chinese medicine (TCM), recently have received strong
interest as the therapeutic drugs for hepatic cancer as they have relatively few side effects and have been long used as alternative remedies for a
variety of diseases including cancer (Shen et al., 2012; Lin et al., 2012). TCM formula is a complex combination of many natural products,
each of which contains numerous chemical compounds. Therefore, TCM formulas are considered to be the multi-component and multi-target
agents exerting their therapeutic function in a more holistic way and discovering naturally-occurring agents is a promising approach for
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anti-cancer treatment (Zhuang et al., 2012). Ciji Hua’ai Baosheng Granule Formula (CHBGF) is the traditional Chinese empirical formula set
up by Yanhui Wang, a famous traditional Chinese physician and Prof. of Xiamen University Medical College. It mainly includes Dangshen
(Radix Codonopsis), Huangqi (Radix Astragali Mongolici), Tiannanxing (Rhizoma Arisaematis Erubescentis), Muli (Concha Ostreae), Lingzhi
(Ganoderma Lucidum), Sanleng (Rhizoma Sparganii), Zaojiaoci (Spina Gleditsiae), Buguzhi (Fructus Psoraleae), Chenpi (Pericarpium Citri
Reticulatae) and Fuling (Poria) etc. (Wang, 2004; Wang et al., 2004). According to the traditional Chinese medical theory, CHBGF can
strengthen vital qi to eliminate pathogenic factor, drastically remove blood stasis, dissipate phlegm and resolve hard masses, and nourish blood.
During the clinical practice we used CHBGF to treat many kinds of tumors postchemotherapy and find that CHBGF can alleviate the tumor
patients’ symptoms, but the correlated study and research have no reports (Wang, 2004; Wang et al., 2004). This study investigated the effect of
CHBGF on the general state of health, tumor inhibition, pathology, survival time, and peripheral blood cells in mouse chemotherapy model
with subcutaneous transplanted tumor or ascitic tumor of H22 hepatoma carcinoma cells to aim at providing modern pharmacology basis for its
clinical application.
Materials and Methods
Animal and Tumor Cell
A total of 92 Kunming mice, with specific pathogen-free (SPF) degree, weighing 18±2g, aged 4-6 weeks, male and female in equal, were
obtained from the Experimental Animal Center of Xiamen University in Xiamen, China [License No. SCXK (Min) 2013-0001]. H22 hepatoma
carcinoma cell suspension was provided by Cancer Research Center of Xiamen University (Xiamen, China), and transferred by the mice
hydroperitoneum once per week.
Experimental Drugs
CHBGF [Dangshen (Radix Codonopsis) 12g, Huangqi (Radix Astragali Mongolici) 10g, Zhebeimu (Bulbus Fritillariae Thunbergii) 10g,
Tiannanxing (Rhizoma Arisaematis Erubescentis) 10g, Chenpi (Pericarpium Citri Reticulatae) 10g, Fuling (Poria) 20g, Houpo (Cortex
Magnoliae Officinalis) 5g, Zhiqiao (Fructus Aurantii Submaturus) 5g, Baizhu (Rhizoma Atractylodis Macrocephalae) 10g, Sharen (Fructus
Amomi) 5g, Yizhiren (Fructus Alpiniae Oxyphyllae) 5g, Baibiandou (Semen Lablab Album) 10g, Maiya (Fructus Hordei Germinatus) 10g,
Sanleng (Rhizoma Sparganii) 10g, Zaojiaoci (Spina Gleditsiae) 10g, Hehuanpi (Cortex Albiziae)15g, Muli (Concha Ostreae) 15g, Lingzhi
(Ganoderma Lucidum) 10g and Buguzhi (Fructus Psoraleae) 10g], each Chinese herb’s formula granule was provided by Jiangyin Tianjiang
Pharmaceutical Co. Ltd. (Jiangyin, China), altogether were equivalent to 192g of crude drug, was stored at -20℃. 5-Fluorouracil for Injection 
was supplied as a colorless fluid, 250mg, 10mL each ampoule, product lot No.120112, was produced by Shanghai Xudong Haipu
Pharmaceutical Co. Ltd. (Shanghai, China). 0.9% Sodium Chloride Injection, 100mL each ampoule, product lot No.120320103, was produced
by Fuzhou Neptunus Fuyao Pharmaceutical Co. Ltd. (Fuzhou, China). CTX (Cyclophosphamide for Injection), 200mg/ampoule, product lot No.
111104, was produced by Jilin Tonghua Mao Xiang Medicine Co. Ltd. (Tonghua, China).
Main Reagents
Dehydrated alcohol (Sanlin Pharma Fujian Co. Ltd.); Haematoxylin staining solution, 0.7% acidized feosin staining solution, methanol,
were all made by Zhongshan Golderbridge Biotechnology Co. Ltd, Beijing, China; 10% neutral Formaldehyde Solution, Distilled Water was
prepared by the laboratory center of Medical College of Xiamen University, Xiamen, China.
Instruments
IDEXX VetAutoread Hematology Analyzer (PT. Sambada healty TBK, JL. Pertinggalan, Indonesia), TGL-16M high-speed refrigerated
centrifuge (Xiang Yi Centrifuge Instrument Co. Ltd, Changsha, China), LeicaRM2035 Histotome (LEICA Co., Solms, Germany), Olympus
B202 Microscope (Olympus Optical Co. Ltd, Tokyo, Japan), SF2000 Electronic Digital Display Calipers (Guilin Guanglu Measuring
Instrument Co., Ltd, Guilin, China), TP-200D and TP-1000A Electronic Balance (Xiang Yi Balance Instrument Co. Ltd, Changsha, China),
Chamber for Counting Blood Cells (Shanghai Qiujing Biochemical Reagent & Instrument Co., Shanghai, China).
Modeling
Hydroperitoneum mice with H22 hepatoma carcinoma cells were transferred until ivory white hydroperitoneum could be sucked. Take
suction of hydroperitoneum at the asepsis condition, drop on the counting slide to count under an inverted microscope (×100). The
concentration was regulated by the normal saline, and the single cell suspension with 3×107 cells/mL was counted by Chamber for Counting
Blood Cells. Select 71 mice randomly. 0.2mL suspension (about 6×106 cells) was inoculated subcutaneously to the right armpit or peritoneal
cavity under the asepsis condition. 7 days later after inoculation, 71 mice that all formed the transplanted tumors, were injected by Cytoxan
(CTX) at the dosage of 200mg/kg to peritoneal cavity to establish the cancer mouse chemotherapy model with subcutaneous transplanted tumor
of H22 hepatoma carcinoma cells. The other 21 mice were injected the same amount of H22 hepatoma carcinoma cells into peritoneal cavity, and
24 hours later, the same method was used to establish the ascitic tumor chemotherapy model.
Mice Breeding
The mice were bred in animal house (SPF degree) with barrier system assisted with apinoid laminar flow chamber in the Experimental
Animal Center of Xiamen University, and used for experiment after 1 week with diet and water access freely.
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Drugs Dispensing
Mix every CHBGF’s drug Granule and completely dissolve with appropriate amount of distilled water to prepare the CHBGF solution
with concentration of 3.2g/mL, 1.6g/mL and 0.8g/mL respectively. Dilute 5-Fluorouracil for Injection by 0.9% Sodium Chloride Injection to
the concentration 1.25mg/mL. And dilute CTX by 0.9% Sodium Chloride Injection.
Animal Grouping and Administering
The 71 mice that had formed tumors were injected by Cytoxan (CTX) (200mg/kg) to establish the mouse chemotherapy model with the
transplanted tumor, and then they were commensurately divided into 8 groups by random digits table. The other 21 mice were divided into 3
groups by the same mean. Two kinds of models, each three groups for evaluating the effects on survival time were model group, CHBGF
group and the positive control group respectively with 7 mice in each group. Another five groups for evaluating the effects on anti-cancer
were model group, the three treatment groups and the positive control group with 10 mice in each group. And then, the
survival-time-observing groups of solid tumor were respectively given intragastric administration of normal saline (0.9%, 0.2mL/10g),
CHBGF (64g/kg, 0.2mL/10g) (equivalence to 20 times of human dosage of medicine material crude slices) once a day, and peritoneal
injection of 5-Fluorouracil (25mg/kg, 0.2mL/10g) once every other day until death emerged in the control group. The
survival-time-observing groups of ascitic tumor were the same administering as the above, but the observing days were the successive 10
days. And then record the survival time of each mouse to calculate the life prolonging rate. The five anti-cancer-observing groups were
respectively given intragastric administration of normal saline (0.9%, 0.2mL/10g), CHBGF (64g/kg, 32g/kg, 16g/kg, 0.2mL/10g) once a day,
and peritoneal injection of 5-Fluorouracil (25mg/kg, 0.2mL/10g) once every other day for successive 21 days.
Life Prolonging Rate and Tumor Inhibition Ratio Calculating
The life prolonging rate (LFR) was calculated. LFR= (average survival days of experimental group-average survival days of control
group)/average survival days of control group×100%. To the five anti-cancer-observing groups, on the next day after administering at the last
time, the mice were weighed, mice were put to death by cervical dislocation according to regulation, and the tumors were peeled off
completely to weigh. The postchemotherapy tumor inhibition rate (IR) was calculated. IR= (average tumor weight of model group-average
tumor weight of medication administration group)/average tumor weight of model group×100%.
Blood Cell Calculating and WBC Blood Smear Observing
Pick the eyeballs to collect peripheral blood on the next day when administration was over, and use VetAutoread Hematology Analyzer
to analyze automatically, and calculate the number of red blood cell (RBC), white blood cell (WBC), hemoglobin (HGB) and blood platelet
(PLT). Meanwhile, drop the blood on one terminal of microscopic slide, and use cover glass with smoothed edge to push blood drop to
spread out evenly, and dry, then drop Wright’s stain to fix the slide for 1 minute, rinse clean and dry naturally. Then the slides were observed
under microscope.
Preparation of Pathological Section and Observation
Fresh tumor tissues were put into formalin neutral solution to fix, and then the tissues were dehydrated routinely and embed with
paraffin to be made serial section with 4μm thickness. The sections were dried at 50℃, stained by haematoxylin, and rinsed with tap water. 
And then they were processed with 70% saline ethanol to separate color, and rinsed following retained with acidizing Feosin, rinsed again,
dehydrated, and cleared. Finally the sections were mounted with neutral balsam, and then put under the inverted microscope. The pathology
in tumors was watched in 400 times fields-of-view to observe oncopathological changes.
Statistics
The data were expressed as ( x ±s) and statistical software, Statistical Product and Service Solutions (SPSS) 19.0 (IBM, Armonk, NY,
USA), was used for one-way analysis of variance [One-Way ANOVA (analysis of variance)]; and the least significant difference (LSD)
method was chosen. P<0.05 was regarded as statistically significant difference.
Results
Effects of CHBGF on Life Prolonging Time of Tumor Mice Chemo-treated
The survival time of subcutaneous transplanted tumor mice and ascitic tumor mice chemo-treated in CHBGF group was obviously
longer than that in the negative control group and 5-Fluorouracil group (P<0.05, P<0.01) (Table 1&2). The life prolonging rates (LFR) of
two CHBGF groups were 20.14% and 64.15% respectively. It hinted that the formula 3.2g/mL CHBGF solution had a certain action to
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prolong the life of both H22 subcutaneous transplanted tumor and ascitic tumor mice chemo-treated.
Table 1: Effect of CHBGF on life prolonging rates (LFR) in mouse chemotherapy model with subcutaneous
transplanted tumor of H22 hepatoma carcinoma cells ( x ±s)
Body weight (g)
Group Dose(g/kg) n
Before administration After administration
Survival time (d) LFR (%)
Model -- 6 22.66±0.83 35.90±3.34 22.00±2.28 --
5-Fluorouracil 0.025 7 22.41±0.70 28.96±2.44a 18.28±2.75a -16.91
CHBGF 64.0 7 22.75±0.86 31.20±4.99 26.43±3.82ac 20.14
Notes: a P<0.05 vs. the model group; c P<0.05 vs. the 5-Fluorouracil group
Table 2: Effect of CHBGF on life prolonging rates (LFR) in mouse chemotherapy model with ascitic tumor of H22
hepatoma carcinoma cells ( x ±s)
Group Dose(g/kg) n Number of survival mouse Survival rate (%) Survival time (d) LFR (%)
Model -- 6 0 0 5.83±0.75 --
5-Fluorouracil 0.025 7 3 42.86 8.00±1.53b 37.22
CHBGF 64.0 7 5 71.43 9.57±0.79bc 64.15
Notes: a P<0.05 vs. the model group; b P<0.01 vs. the model group; c P<0.05 vs. the 5-Fluorouracil group
Table 3: Effect of CHBGF on tumor weight in mouse chemotherapy model with subcutaneous transplanted tumor of
H22 hepatoma carcinoma cells ( x ±s)
Body weight
Group Dose(g/kg) n Before administration After administration
Tumor weight (g) IR(%)
Model -- 9 20.66±1.18 33.47±3.33 1.22±0.30 --
5-Fluorouracil 0.025 7 20.85±1.16 28.85±2.54a 0.40±0.09b 67.21
CHBGF(high) 64.0 9 20.92±0.83 31.91±3.28c 0.84±0.17b 31.15
CHBGF(middle) 32.0 8 20.55±1.00 30.90±3.26 0.96±0.16a 21.31
CHBGF(low) 16.0 9 20.75±0.79 31.56±1.96 1.06±0.34 13.11
Notes: a P<0.05 vs. the model group; bP<0.01 vs. the model group; c P<0.05 vs. the 5-Fluorouracil group
Table 4: Effect of CHBGF on peripheral blood cells in mouse chemotherapy model with subcutaneous transplanted
tumor of H22 hepatoma carcinoma cells ( x ±s)
Group Dose (g/kg) n PLT (×109/L) RBC (×1012/L) WBC (×109/L) HGB (g/L)
Model -- 9 176.67±17.97 10.28±0.76 6.72±1.14 156.89±6.49
5-Fluorouracil 0.025 7 171.71±11.64 10.87±0.75 5.50±0.81ac 150.14±9.86
CHBGF(high) 64.0 9 246.22±35.42bd 11.10±0.80a 9.79±1.01bd 160.56±7.35c
CHBGF(middle) 32.0 8 225.38±30.54bd 10.27±0.52 7.84±0.63ad 157.50±8.32
CHBGF(low) 16.0 9 219.56±32.86bd 10.25±0.90 7.40±1.42ad 151.22±9.73
Notes: a P<0.05, bP<0.01 vs. the model group; c P<0.05, d P<0.01 vs. the 5-Fluorouracil group
Inhibitory Effects of CHBGF on Growth of Transplanted Tumor Chemo-treated
The average tumor weight of the CHBGF (64g/kg), CHBGF (32g/kg) groups and 5-Fluorouracil groups was lower than that of model
group (P<0.05; P<0.01), and the postchemotherapy inhibition rates (IR) of four treated groups were 67.21%, 31.15%, 21.31%, and 13.11%
respectively. It manifested that CHBGF with a certain concentration had an inhibitory action to the growth of H22 transplanted tumor by
chemo-treated (Table 3).
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Effects of CHBGF on Pathological Change of Transplanted Tumor Chemo-treated
Most tumor masses when peeled off had clear dividing lines in tissue; some of them had invaded adhesions. The tumors were light red
and show as ellipsoids, their texture was hard, and had pallid tissue section. Most of the tumor tissue in model group had sublobe, and
unsmooth, irregular surface. Under the inverted microscope, a great quantity of H22 hepatoma carcinoma cells could be seen in tumor tissue
of each group; they show as round or oval shape, different sizes and disordered arrangement; their nuclei were stained to deep blue and some
were large karyoplasm. The tumor tissue in model group had very conferted and scrambled cancer cells arrangement, and more
megakaryocytes with deep staining, and obvious karyokinesis; proliferation of H22 hepatoma carcinoma cells was high. After treatment, the
tumor tissue in the 5-Fluorouracil group shows the sparse distribution of H22 hepatoma carcinoma cells, more interstitial substances, and few
megakaryocytes and appearance of karyokinesis. The tumor tissue in the CHBGF (64g/kg), CHBGF (32g/kg) groups were the slight
concentration of H22 hepatoma carcinoma cells; the disordered arrangement of cancer cell was not more than that of model group, the
appearance of karyokinesis and cell distribution were also fewer than that in the model group (Figure 1).
A B C
D E
Figure 1: Pathological diagram of the chemo-treated transplanted tumor of H22 hepatoma carcinoma cells in each group (400×, HE staining).
A: Model group; B: 5-Fluorouracil group; C: CHBGF (high) group; D: CHBGF (middle) group; E: CHBGF (low) group.
A B C
D E
Figure 2: Blood smear diagram of the chemo-treated transplanted tumor of H22 hepatoma carcinoma cells in each group (400×, Wright
staining). A: Model group; B: 5-Fluorouracil group; C: CHBGF (high) group; D: CHBGF (middle) group; E: CHBGF (low) group.
Effects of CHBGF on Peripheral Blood Cells of Transplanted Tumor Mice Chemo-treated
Compared with the model and the 5-Fluorouracil groups, the number of WBC and PLT in three CHBGF groups was obviously more
than that of the other two groups (P<0.05; P<0.01). But the number of RBC and HGB just in the CHBGF (64g/kg) group was more than that
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of model group or the 5-Fluorouracil group (P<0.05) (Table 4). Under the microscope, the red blood cells manifested slightly purple red
color; the white blood cells were stained to deep blue color. The number of WBC of the continuous chemotherapy group was quite few. WBC
number of the three CHBGF group was big which was obviously more than that of the model and 5-Fluorouracil group (Figure 2). The blood
smear pictures were in line with the results of peripheral blood analyzed automatically by Hematology Analyzer. These results manifested
that CHBGF with a certain concentration had a promotive effect on the upswing of WBC reduced by chemotherapy and antagonizing the
reduction of PLT.
Discussion
Malignant tumor is one of the clinical refractory diseases, especially the hepatic carcinoma, which has a swift progression, a short
natural life span, and the death rate at the middle and advanced stage of which is high, so now there is still no commendable therapeutic
method to treat it. The classical chemotherapy often brings about many more serious toxic and side-effects to the patients and makes them
hard to bear. Peripheral blood cells count is one of the routine examination targets for chemotherapy, which can reflect the immune state.
Recent research data manifested that about 90% of the tumor patients who had been received chemotherapy would show the bone marrow
depression symptom of WBC reduction; the severe patient may suffer serious infection, even life was threatened (Zhang et al., 2013; Li et al.,
2013). Traditional Chinese medicine thinks that liver cancer has the syndrome of intermingled deficiency and excess. “Deficiency” mainly
lies in qi deficiency of spleen, yin deficiency of liver and kidney, yang deficiency of spleen and kidney, and “excess” mainly lies in qi
stagnation and blood stasis, dampness heat and stagnated toxin (Wang et al., 2009). To the treatment, TCM physicians should strengthen
spleen and fortify the center, regulate the qi movement, remove toxic substance, and activate blood circulation to dissipate blood stasis. To
the patient in the advanced stage, they should often fortify the spleen and nourish the kidney, consolidate body resistance and bank up the
original qi. Chemotherapy, TCM thought it was one kind of pathogenic toxin compared with healthy qi (Wang, 2004). TCM treatment of
tumor after chemotherapy, should be given more emphasis on fortifying the spleen and boosting qi, and supplementing kidney and essence
that combined removing phlegm, stasis and stagnation by Prof. Yanhui Wang (Wang et al., 2004). In formula “CHBGF”, Dangshen (Radix
Codonopsis) matching Huangqi (Radix Astragali Mongolici), Chenpi (Pericarpium Citri Reticulatae), Fuling (Poria), etc., can boost,
regulate qi and fortify the spleen; Sanleng (Rhizoma Sparganii) and Zaojiaoci (Spina Gleditsiae) can invigorate blood and dissolve stasis;
Tiannanxing (Rhizoma Arisaematis Erubescentis), Zhebeimu (Bulbus Fritillariae Thunbergii) and Muli (Concha Ostreae) can dissolve
phlegm and dissipate masses; Lingzhi (Ganoderma Lucidum) can supplement the deficiency; Hehuanpi (Cortex Albiziae) and Muli (Concha
Ostreae) can calm the mind, Buguzhi (Fructus Psoraleae) can supplement the kidney, which are quite in line with the therapeutic principles
for liver cancer after chemotherapy.
This experimental results show that CHBGF could not only prolong the survival time of mouse chemotherapy model with solid and
ascitic tumor of H22 hepatoma carcinoma cells, but also inhibit synergistically the growth of transplanted tumor chemo-treated. The
inhibition ratio was inferior to that of 5- Fluorouracil, but in the aspect of the body weight change in anterior-posterior experiments, the toxic,
side-effects and the follow-up survival time of tumor retention, 5- Fluorouracil could improve the inhibition ratio but not yet prolong the
survival time. Though the direct tumoricidal efficacy of CHBGF was not as good as chemotherapy drug, the inhibitory action existed in all
three dosage groups of CHBGF, and the increasing of body weight of the three groups of CHBGF was more than the continuous
chemotherapy mice. The upswing of WBC reduced by chemotherapy and the antagonizing effect on PLT reduction of the three CHBGF
groups, and the number of RBC and HGB just in the CHBGF (64g/kg) group were all more obvious than the model and continuous
chemotherapy mice, which manifested that CHBGF had a certain action on relieving the toxic and side-effects caused by chemotherapy, and
this formula was worth further studying and researching.
The chemotherapy for tumor and the benefits of patients obtained from the treatment were often ignored by modern medicine doctors to
some degree, but the application of Chinese materia medica was more and more thought highly of. The antagonizing tumor of Chinese
medicinals has their unique advantages. At present, the therapeutic effects of Chinese medicinal or its chief components mainly concentrate
upon improving immunity (Zhang et al., 2010), inhibiting tumor capillary angiogenesis (Xi et al., 2012) and metastasis (Li et al., 2012),
killing the neoplastic cells directly (Xu et al., 2005), promoting them apoptosis (He et al., 2012) and so on. So formula may play a
multi-target, multi-angle and multi-path anticancer effectiveness, such as to increase the tolerance of body to chemotherapy, relieve the
adverse reactions, and then reduce the complications and improve the curative effect. In the formula “CHBGF”, some recent researches show
that coarse polysaccharides of Dangshen (Radix Codonopsis) could inhibit the S180 ascites tumor (Li et al., 2011), parenteral solution of
Huangqi (Radix Astragali Mongolici) could restrain tumor growth of tumor-bearing mice whose mechanism was likely related to improve
mice’s cellular immune function (Fan et al., 2013), and Huangqi polyoses (astragalin) also can prevent leukopenia of carcinoma of large
intestine caused by chemotherapy (Lv et al., 2009), combined with Lingzhi (Ganoderma Lucidum) which may be more effective on WBC
(Zhang et al., 2012), Sanleng (Rhizoma Sparganii) and some components of Chenpi (Pericarpium Citri Reticulatae) which can induce
apoptosis of hepatoma carcinoma cells (Li et al., 2006; Li et al., 2009), and Psoralen, component of Buguzhi (Fructus Psoraleae), some
components of Fuling (Poria) which both had the antineoplasmic activity (Wu et al., 1998; Cheng et al., 2008), Buguzhi (Fructus Psoraleae)
which can also increase the WBC number reduced by CTX (Lin et al., 2007), Tiannanxing (Rhizoma Arisaematis Erubescentis), Muli
(Concha Ostreae), Lingzhi (Ganoderma Lucidum) and Zaojiaoci (Spina Gleditsiae) which may all antagonize transplanted tumor through
strengthening immunity (Wang et al., 1997; Jin et al., 2011; Liu et al., 2009). So it is thus clear that the anti-cancer or anti-side-effect action
of every Chinese medicine of CHBGF chosen by Prof. Yanhui Wang has been confirmed by animal or clinical experiments.
This study first confirmed that “CHBGF”, the empirical formula, can prolong the life span of mouse chemotherapy model of H22
hepatoma carcinoma cells, also has a certain action on inhibiting their growth of tumor, meanwhile, it can antagonize the reduction of WBC
and PLT caused by chemotherapy, which provides some experimental data for the TCM clinical treatment to postchemotherapy of tumor at
the angle of integrated pharmacodynamics. And its concrete mechanisms will be the next investigative focal points.
Xi et al., Afr J Tradit Complement Altern Med. (2014) 11(4):94-100
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